284 related articles for article (PubMed ID: 21199698)
21. Preparing for H1N1 influenza: New Jersey preparedness efforts ongoing for nearly a decade.
Howard H
MD Advis; 2009; 2(4):23-6. PubMed ID: 21250538
[No Abstract] [Full Text] [Related]
22. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients.
Altamirano-Diaz L; West L; Humar A; Ely L; Urschel S; Gubbay J; Crowcroft N; Kumar D
Pediatr Transplant; 2011 Mar; 15(2):172-5. PubMed ID: 21176017
[TBL] [Abstract][Full Text] [Related]
23. Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals.
Kajaste-Rudnitski A; Galli L; Nozza S; Tambussi G; Di Pietro A; Pellicciotta G; Monti A; Mascagni P; Moro M; Vicenzi E
AIDS; 2011 Jan; 25(2):177-83. PubMed ID: 21150561
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of Ontario's pandemic vaccine program.
Rolland-Harris E; Tepper M
Vaccine; 2011 May; 29(22):3829; author reply 3830-1. PubMed ID: 20831912
[No Abstract] [Full Text] [Related]
25. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic.
Gaygısız Ü; Gaygısız E; Özkan T; Lajunen T
Vaccine; 2010 Dec; 29(2):329-33. PubMed ID: 20979988
[TBL] [Abstract][Full Text] [Related]
26. Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism.
Yin JK; Wang H; Skinner SR; Salkeld G; Booy R
Aust N Z J Public Health; 2011 Aug; 35(4):393-4. PubMed ID: 21806738
[No Abstract] [Full Text] [Related]
27. [Pandemic vaccines].
Floret D
Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
[No Abstract] [Full Text] [Related]
28. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258
[TBL] [Abstract][Full Text] [Related]
29. How did the 2008-2009 seasonal influenza vaccine affect the pandemic?
Glezen WP
Clin Infect Dis; 2010 Dec; 51(12):1380-2. PubMed ID: 21067354
[No Abstract] [Full Text] [Related]
30. [The safety and immunogenicity of the vaccines against pandemic (H1N1) 2009 influenza].
Grotto I; Engelhard D
Harefuah; 2009 Dec; 148(12):799-803, 857. PubMed ID: 20088428
[TBL] [Abstract][Full Text] [Related]
31. [Development of influenza vaccines against pandemics].
Itamura S
Nihon Rinsho; 2000 Nov; 58(11):2321-6. PubMed ID: 11225324
[TBL] [Abstract][Full Text] [Related]
32. A pandemic influenza vaccine in India: from strain to sale within 12 months.
Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S
Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421
[TBL] [Abstract][Full Text] [Related]
33. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
Collin N; de Radiguès X;
Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
[TBL] [Abstract][Full Text] [Related]
34. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
[TBL] [Abstract][Full Text] [Related]
35. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
[TBL] [Abstract][Full Text] [Related]
36. Influenza pandemics, immune cross-reactivity, and pandemic control strategies.
Gioia C; Agrati C; Castilletti C; Capobianchi MR; Martini F
J Infect Dis; 2008 Jul; 198(2):294-5; author reply 295-6. PubMed ID: 18593297
[No Abstract] [Full Text] [Related]
37. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
[TBL] [Abstract][Full Text] [Related]
38. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.
Rodríguez-Rieiro C; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; Iniesta-Fornies D; Barranco-Ordoñez D; Cameno-Heras M; Jiménez-García R
Vaccine; 2011 Feb; 29(6):1332-8. PubMed ID: 21182996
[TBL] [Abstract][Full Text] [Related]
39. Seasonal influenza vaccine provides priming for A/H1N1 immunization.
Del Giudice G; Stittelaar KJ; van Amerongen G; Simon J; Osterhaus AD; Stöhr K; Rappuoli R
Sci Transl Med; 2009 Dec; 1(12):12re1. PubMed ID: 20371459
[TBL] [Abstract][Full Text] [Related]
40. Experience from influenza A (H1N1) pandemic 2009--is prevention better than cure?
Parikh FS
J Assoc Physicians India; 2011 Jan; 59():11-2. PubMed ID: 21751658
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
